MPH Health Care AG Receives Updated Buy Rating from First Berlin Equity Research

First Berlin Equity Research GmbH has maintained its "BUY" rating on MPH Health Care AG and increased the target price from EUR 62.00 to EUR 81.00. Analyst Ellis Acklin cited the company's solid performance in its preliminary 2023 results as a key factor for the updated evaluation.

The report highlighted a 16% increase in the Year End 2023 Net Asset Value, significantly influenced by a 20% rise in M1 Kliniken shares during the final quarter of the year. This growth was attributed to strong performance in the lifestyle and beauty segments, particularly in the injectables business, which exceeded margin expectations.

Although CR Energy reported a decrease in EBIT from EUR 75 million in 2022 to EUR 65 million in 2023, its focus on renewable energy solutions is expected to yield positive future outcomes. Terrabau's niche in affordable green homes also continues to give it an edge in a challenging real estate market impacted by rising financing costs.

Moreover, MPH Health Care AG plans to propose a dividend of EUR 1.20 per share at the upcoming Annual General Meeting on July 18, an announcement likely to be well received by investors. The rise in M1's fair value to €18 per share, up from €11.90, has played a significant role in increasing the overall target price.